Clinical Trials Directory

Trials / Completed

CompletedNCT04031222

Mechanisms of Inflammation, Immunity, Islet Cell and Intestinal Hormone Changes in Youth at Risk for Diabetes

Mechanisms of Inflammation, Immunity, Islet Cell and Intestinal Hormone Changes in Youth at Risk for Diabetes (MI4D)

Status
Completed
Phase
Study type
Observational
Enrollment
52 (actual)
Sponsor
The Hospital for Sick Children · Academic / Other
Sex
All
Age
12 Years – 18 Years
Healthy volunteers
Not accepted

Summary

This study intends to assess the role of inflammation in insulin resistant conditions (i.e., obesity and pre-diabetes) and the subsequent development of disease, such as type 2 diabetes (T2D) and cardiovascular disease (CVD), in the adolescent population.

Detailed description

This study proposes to characterize inflammatory biomarkers, insulin resistance and fecal microbiome composition in obese/pre-diabetic adolescents after glucose ingestion, followed by an oral fat tolerance test on a separate visit. Lipoprotein abnormalities and intestinal biomarkers, post-lipid ingestion, will also be evaluated. The primary aim is to assess the role of inflammation in insulin resistant conditions (i.e., obesity and pre-diabetes) and the subsequent development of disease, such as type 2 diabetes (T2D) and cardiovascular disease (CVD), in the adolescent population.

Conditions

Timeline

Start date
2017-05-19
Primary completion
2019-02-15
Completion
2019-03-01
First posted
2019-07-24
Last updated
2022-09-13

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT04031222. Inclusion in this directory is not an endorsement.